Loading
CARTx Therapeutics
CARTx Therapeutics, spun out of Nationwide Children's Hospital, is developing affordable off-the-shelf CAR gamma-delta T cell therapies from healthy donors for solid tumours and blood cancers.
Overview
CARTx Therapeutics uses polyclonal gamma-delta T cells from healthy donors, engineered with chimeric antigen receptors, to make allogeneic cell therapies that do not need to be manufactured from each patient, aiming at lower cost and faster access for solid tumours and blood cancers.
Headquarters
United States (city not published), US
Type
Stage
Startup
Website
Connected
2technologies
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
cartx.health · 1
sijbrandijfoundation.org · 1
A source that has moved or gone is reported by the weekly link check. /audit/